Hemorrhagic Mortality A Problem for APL Patients

Even though the rate of complete remission of acute promyelocytic leukemia (APL) is currently more than 90% because of the use of all-trans retinoic acid (ATRA) with arsenic trioxide (ATO), hemorrhagic mortality has emerged as the most significant barrier to APL-induced remission, according to a new study.

SMASH2 Scoring System Better Predicts Atrial Fibrillation

CHICAGO — Atrial fibrillation-associated morbidity and mortality are on the increase, and a new study pointed out the critical need for improved surveillance and prevention strategies to reduce the condition which can lead to strokes. The report in The Journal...